174 related articles for article (PubMed ID: 19496283)
1. [Inhibitors for Notch and gamma-secretase. Biology of T-cell leukemia].
Yahagi Y; Usui N
Gan To Kagaku Ryoho; 2009 May; 36(5):744-8. PubMed ID: 19496283
[No Abstract] [Full Text] [Related]
2. [Biology and pathobiology of the intramembrane proteolysis by gamma-secretase].
Tomita T
Tanpakushitsu Kakusan Koso; 2009 Oct; 54(13):1747-53. PubMed ID: 19827607
[No Abstract] [Full Text] [Related]
3. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.
Lewis HD; Leveridge M; Strack PR; Haldon CD; O'neil J; Kim H; Madin A; Hannam JC; Look AT; Kohl N; Draetta G; Harrison T; Kerby JA; Shearman MS; Beher D
Chem Biol; 2007 Feb; 14(2):209-19. PubMed ID: 17317574
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
Nefedova Y; Gabrilovich D
Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834
[TBL] [Abstract][Full Text] [Related]
6. Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model.
Masuda S; Kumano K; Suzuki T; Tomita T; Iwatsubo T; Natsugari H; Tojo A; Shibutani M; Mitsumori K; Hanazono Y; Ogawa S; Kurokawa M; Chiba S
Cancer Sci; 2009 Dec; 100(12):2444-50. PubMed ID: 19775286
[TBL] [Abstract][Full Text] [Related]
7. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells.
Kogoshi H; Sato T; Koyama T; Nara N; Tohda S
Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349
[TBL] [Abstract][Full Text] [Related]
8. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
10. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises.
Sarmento LM; Barata JT
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1403-15. PubMed ID: 21929314
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
[TBL] [Abstract][Full Text] [Related]
13. Gamma-secretase complexes regulate the responses of human pancreatic ductal adenocarcinoma cells to taxanes.
Tasaka T; Akiyoshi T; Yamaguchi K; Tanaka M; Onishi H; Katano M
Anticancer Res; 2010 Dec; 30(12):4999-5010. PubMed ID: 21187481
[TBL] [Abstract][Full Text] [Related]
14. Novel Notch-sparing gamma-secretase inhibitors derived from a peroxisome proliferator-activated receptor agonist library.
Kurosumi M; Nishio Y; Osawa S; Kobayashi H; Iwatsubo T; Tomita T; Miyachi H
Bioorg Med Chem Lett; 2010 Sep; 20(17):5282-5. PubMed ID: 20650635
[TBL] [Abstract][Full Text] [Related]
15. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
16. Small molecules that inhibit Notch signaling.
De Kloe GE; De Strooper B
Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499
[TBL] [Abstract][Full Text] [Related]
17. [Functional analysis of notch in the pathophysiology of leukemia].
Tohda S
Rinsho Byori; 2009 Apr; 57(4):351-6. PubMed ID: 19489437
[TBL] [Abstract][Full Text] [Related]
18. Rethinking Gamma-secretase Inhibitors for Treatment of Non-small-Cell Lung Cancer: Is Notch the Target?
Pine SR
Clin Cancer Res; 2018 Dec; 24(24):6136-6141. PubMed ID: 30104200
[TBL] [Abstract][Full Text] [Related]
19. Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies.
Gao L; Yuan K; Ding W; Lin M
Crit Rev Eukaryot Gene Expr; 2016; 26(3):239-46. PubMed ID: 27650987
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.
Groth C; Fortini ME
Semin Cell Dev Biol; 2012 Jun; 23(4):465-72. PubMed ID: 22309842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
